OCA at 12:31, 4 October 2023

OCA — Wed, 04 Oct 2023 12:31:35 GMT

←Older revision		Revision as of 12:31, 4 October 2023
Line 1:		Line 1:
-	'''Unreleased structure'''

-	~~The entry~~ 8cm9 is ~~ON HOLD until Paper Publication~~	+	==Structure of human O-GlcNAc transferase in complex with UDP and tP11==
-		+	<StructureSection load='8cm9' size='340' side='right'caption='[[8cm9]], [[Resolution\|resolution]] 2.80Å' scene=''>
-	~~Authors~~:	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[8cm9]] is a 8 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Synthetic_construct Synthetic construct]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=8CM9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=8CM9 FirstGlance]. <br>
-	~~Description~~:	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 2.8Å</td></tr>
-	[[Category: ~~Unreleased~~ Structures]]	+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=UDP:URIDINE-5-DIPHOSPHATE'>UDP</scene></td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8cm9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8cm9 OCA], [https://pdbe.org/8cm9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8cm9 RCSB], [https://www.ebi.ac.uk/pdbsum/8cm9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8cm9 ProSAT]</span></td></tr>
		+	</table>
		+	== Disease ==
		+	[https://www.uniprot.org/uniprot/OGT1_HUMAN OGT1_HUMAN] Regulation of OGT activity and altered O-GlcNAcylations are implicated in diabetes and Alzheimer disease. O-GlcNAcylation of AKT1 affects insulin signaling and, possibly diabetes. Reduced O-GlcNAcylations and resulting increased phosphorylations of MAPT/TAU are observed in Alzheimer disease (AD) brain cerebrum.
		+	== Function ==
		+	[https://www.uniprot.org/uniprot/OGT1_HUMAN OGT1_HUMAN] Catalyzes the transfer of a single N-acetylglucosamine from UDP-GlcNAc to a serine or threonine residue in cytoplasmic and nuclear proteins resulting in their modification with a beta-linked N-acetylglucosamine (O-GlcNAc). Glycosylates a large and diverse number of proteins including histone H2B, AKT1, PFKL, KMT2E/MLL5, MAPT/TAU and HCFC1. Can regulate their cellular processes via cross-talk between glycosylation and phosphorylation or by affecting proteolytic processing. Involved in insulin resistance in muscle and adipocyte cells via glycosylating insulin signaling components and inhibiting the 'Thr-308' phosphorylation of AKT1, enhancing IRS1 phosphorylation and attenuating insulin signaling. Involved in glycolysis regulation by mediating glycosylation of 6-phosphofructokinase PFKL, inhibiting its activity. Component of a THAP1/THAP3-HCFC1-OGT complex that is required for the regulation of the transcriptional activity of RRM1. Plays a key role in chromatin structure by mediating O-GlcNAcylation of 'Ser-112' of histone H2B: recruited to CpG-rich transcription start sites of active genes via its interaction with TET proteins (TET1, TET2 or TET3). As part of the NSL complex indirectly involved in acetylation of nucleosomal histone H4 on several lysine residues.<ref>PMID:12150998</ref> <ref>PMID:18288188</ref> <ref>PMID:19451179</ref> <ref>PMID:19377461</ref> <ref>PMID:20018852</ref> <ref>PMID:20018868</ref> <ref>PMID:20200153</ref> <ref>PMID:20824293</ref> <ref>PMID:21285374</ref> <ref>PMID:22121020</ref> <ref>PMID:22923583</ref> <ref>PMID:23353889</ref> <ref>PMID:23222540</ref> <ref>PMID:15361863</ref> <ref>PMID:21240259</ref> Isoform 2: the mitochondrial isoform (mOGT) is cytotoxic and triggers apoptosis in several cell types including INS1, an insulinoma cell line.<ref>PMID:12150998</ref> <ref>PMID:18288188</ref> <ref>PMID:19451179</ref> <ref>PMID:19377461</ref> <ref>PMID:20018852</ref> <ref>PMID:20018868</ref> <ref>PMID:20200153</ref> <ref>PMID:20824293</ref> <ref>PMID:21285374</ref> <ref>PMID:22121020</ref> <ref>PMID:22923583</ref> <ref>PMID:23353889</ref> <ref>PMID:23222540</ref> <ref>PMID:15361863</ref> <ref>PMID:21240259</ref>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Homo sapiens]]
		+	[[Category: Large Structures]]
		+	[[Category: Synthetic construct]]
		+	[[Category: Davies GJ]]
		+	[[Category: Meek RW]]

OCA at 05:35, 22 March 2023

OCA — Wed, 22 Mar 2023 05:35:38 GMT

←Older revision		Revision as of 05:35, 22 March 2023
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 8cm9 is ON HOLD	+	The entry 8cm9 is ON HOLD until Paper Publication

	Authors:		Authors:

OCA: Protected "8cm9" [edit=sysop:move=sysop]

OCA — Thu, 02 Mar 2023 04:20:50 GMT

Protected "8cm9" [edit=sysop:move=sysop]

←Older revision

Revision as of 04:20, 2 March 2023

OCA: New page: '''Unreleased structure''' The entry 8cm9 is ON HOLD Authors: Description: Category: Unreleased Structures

OCA — Thu, 02 Mar 2023 04:20:49 GMT

New page: '''Unreleased structure''' The entry 8cm9 is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 8cm9 is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]

8cm9 - Revision history

OCA at 12:31, 4 October 2023

OCA at 05:35, 22 March 2023

OCA: Protected "8cm9" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 8cm9 is ON HOLD Authors: Description: Category: Unreleased Structures